Regulus Therapeutics Inc. (RGLS) Jumps 9% on January 20

Equities Staff |

Regulus Therapeutics Inc. (RGLS) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 9% to $6.54, representing a gain of $0.54 per share. Some 332,210 shares traded hands on 3,559 trades, compared with an average daily volume of 532,125 shares out of a total float of 52.34 million. The stock opened at $5.98 and traded with an intraday range of $6.55 to $5.55.

After today's gains, Regulus Therapeutics Inc. reached a market cap of $342.32 million. Regulus Therapeutics Inc. has had a trading range between $21.22 and $5.80 over the last year, and it had a 50-day SMA of $8.84 and a 200-day SMA of $9.87.

Regulus Therapeutics Inc is a biopharmaceutical company. The Company is engaged in discovering and developing drugs that target micro RNAs to treat various diseases.

Regulus Therapeutics Inc. is based out of San Diego, CA and has some 82 employees. Its CEO is Paul C. Grint.

For a complete fundamental analysis analysis of Regulus Therapeutics Inc., check out’s Stock Valuation Analysis report for RGLS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…